molindone has been researched along with trifluoperazine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ernsberger, P; Hufeisen, SJ; Jayathilake, K; Kroeze, WK; Meltzer, HY; Popadak, BA; Renock, SM; Roth, BL; Steinberg, S | 1 |
| Balogh, I; Kim, HY; Koczok, K; Korade, Z; Liu, W; Mirnics, K; Porter, NA; Tallman, KA; Xu, L | 1 |
| Berger, SH | 1 |
| Davis, JM | 1 |
| Slack, T; Stoudemire, A | 1 |
| Eper, E; Güven, F; Hsu, W; Itil, TM; Polvan, N; Ucok, A | 1 |
| Creese, I; DePaulo, JR; Slavney, PR; Snyder, SH; Tune, LE | 1 |
3 trial(s) available for molindone and trifluoperazine
| Article | Year |
|---|---|
Molindone--a new antipsychotic drug.
Topics: Acute Disease; Antipsychotic Agents; Butyrophenones; Chronic Disease; Clinical Trials as Topic; Drug Administration Schedule; Drug Evaluation; Humans; Indoles; Molindone; Movement Disorders; Schizophrenia; Thioxanthenes; Trifluoperazine | 1975 |
Recent developments in the drug treatment of schizophrenia.
Topics: Chlorpromazine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Evaluation; Drug Resistance; Fluphenazine; Humans; Loxapine; Molindone; Phenothiazines; Placebos; Promazine; Research Design; Schizophrenia; Structure-Activity Relationship; Tranquilizing Agents; Trifluoperazine | 1976 |
Comparison of the clinical and electroencephalographical effects of molindone and trifluoperazine in acute schizophrenic patients.
Topics: Acute Disease; Adolescent; Adult; Antidepressive Agents; Brain; Clinical Trials as Topic; Electroencephalography; Evaluation Studies as Topic; Female; Humans; Indoles; Male; Middle Aged; Molindone; Placebos; Psychiatric Status Rating Scales; Schizophrenia; Trifluoperazine | 1971 |
5 other study(ies) available for molindone and trifluoperazine
| Article | Year |
|---|---|
H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs.
Topics: Animals; Antipsychotic Agents; Discriminant Analysis; Drug Evaluation, Preclinical; Forecasting; Humans; Protein Binding; Receptors, Histamine H1; Statistics, Nonparametric; Weight Gain | 2003 |
The Effect of Small Molecules on Sterol Homeostasis: Measuring 7-Dehydrocholesterol in Dhcr7-Deficient Neuro2a Cells and Human Fibroblasts.
Topics: Animals; Cell Line; Dehydrocholesterols; Dose-Response Relationship, Drug; Fibroblasts; Homeostasis; Humans; Mice; Molecular Conformation; Neurons; Oxidoreductases Acting on CH-CH Group Donors; Small Molecule Libraries; Sterols; Structure-Activity Relationship | 2016 |
Trifluoperazine and haloperidol: sources of ejaculatory pain?
Topics: Adult; Ejaculation; Haloperidol; Humans; Male; Molindone; Pain; Psychotic Disorders; Trifluoperazine | 1979 |
Reinstitution of neuroleptic treatment with molindone in a patient with a history of neuroleptic malignant syndrome.
Topics: Adolescent; Bipolar Disorder; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electroconvulsive Therapy; Humans; Indoles; Intellectual Disability; Lithium; Lithium Carbonate; Male; Molindone; Neuroleptic Malignant Syndrome; Trifluoperazine | 1989 |
Neuroleptic serum levels measured by radioreceptor assay and clinical response in schizophrenic patients.
Topics: Adult; Aged; Antipsychotic Agents; Chlorpromazine; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Molindone; Radioligand Assay; Schizophrenia; Thioridazine; Thiothixene; Trifluoperazine | 1981 |